Detalhe da pesquisa
1.
Neoadjuvant nivolumab plus chemotherapy in resectable non-small-cell lung cancer in Japanese patients from CheckMate 816.
Cancer Sci
; 115(2): 540-554, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38098261
2.
The Role of Emphysema on Postoperative Prognosis in Early-Stage Nonsmall Cell Lung Cancer.
Ann Surg Oncol
; 2024 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38739235
3.
Differences in postoperative prognosis between early-stage lung adenocarcinoma and squamous cell carcinoma.
Jpn J Clin Oncol
; 2024 Apr 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38677985
4.
Association between prognosis and lymph node status using 18F-fluorodeoxyglucose-positron emission tomography in esophageal squamous cell carcinoma treated with esophagectomy post-neoadjuvant chemotherapy.
World J Surg
; 48(3): 650-661, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38686781
5.
Risk factors for recurrence of esophageal squamous cell carcinoma after pathological complete response to neoadjuvant therapy followed by esophagectomy.
World J Surg
; 2024 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38757868
6.
Prognostic factors for esophageal squamous cell carcinoma without pathological lymph node metastasis after neoadjuvant therapy and surgery.
World J Surg
; 48(2): 416-426, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38310312
7.
The treatment efficacy and prognosis of each treatment in early postoperative recurrence of esophageal squamous cell carcinoma.
Surg Today
; 54(1): 53-63, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37225930
8.
Second-line tislelizumab versus chemotherapy in Japanese patients with advanced or metastatic esophageal squamous cell carcinoma: subgroup analysis from RATIONALE-302.
Esophagus
; 21(2): 102-110, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38240916
9.
Pembrolizumab plus chemotherapy in Japanese patients with metastatic squamous non-small-cell lung cancer in KEYNOTE-407.
Cancer Sci
; 114(8): 3330-3341, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37183528
10.
Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial.
Lancet
; 399(10335): 1607-1617, 2022 04 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35461558
11.
Hypoxia-inducible factor 1α modulates interstitial pneumonia-mediated lung cancer progression.
J Transl Med
; 21(1): 857, 2023 11 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38012636
12.
Distribution and prognostic impact of EGFR and KRAS mutations according to histological subtype and tumor invasion status in pTis-3N0M0 lung adenocarcinoma.
BMC Cancer
; 23(1): 248, 2023 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36918771
13.
Preoperative predictors for recurrence sites associated with poor post-recurrence survival after surgery of non-small cell lung cancer: a multicenter study.
BMC Cancer
; 23(1): 1064, 2023 Nov 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37926846
14.
Clinicopathologic study of stage I adenosquamous carcinoma of the lung.
Jpn J Clin Oncol
; 53(12): 1201-1207, 2023 Dec 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37681230
15.
A multicenter propensity score-matched analysis of lymphadenectomy in N1-positve lung cancer.
Jpn J Clin Oncol
; 53(12): 1183-1190, 2023 Dec 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37622593
16.
Long-term results of chemoradiotherapy with elective nodal irradiation for resectable locally advanced esophageal cancer in three-dimensional planning system.
Int J Clin Oncol
; 28(3): 382-391, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36646953
17.
Feasibility of repeated ipsilateral anatomical pulmonary resection.
Surg Today
; 53(3): 379-385, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36260165
18.
[Dawn of Radical Segmentectomy for Small Sized Peripheral Non-small Cell Lung Cancer].
Kyobu Geka
; 76(1): 4-8, 2023 Jan.
Artigo
em Japonês
| MEDLINE | ID: mdl-36731826
19.
Effectiveness of taxanes following nivolumab in patients with advanced esophageal squamous cell carcinoma: a retrospective chart review of patients in ATTRACTION-3.
Esophagus
; 20(2): 302-308, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36564602
20.
First-line nivolumab plus ipilimumab or chemotherapy versus chemotherapy alone in advanced esophageal squamous cell carcinoma: a Japanese subgroup analysis of open-label, phase 3 trial (CheckMate 648/ONO-4538-50).
Esophagus
; 20(2): 291-301, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36401133